Imperial College London

ProfessorSebastianJohnston

Faculty of MedicineNational Heart & Lung Institute

Asthma UK Clinical Chair
 
 
 
//

Contact

 

+44 (0)7931 376 544s.johnston

 
 
//

Assistant

 

Mr Christophe Tytgat +44 (0)20 7594 3849

 
//

Location

 

343Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Johnston:2020:10.1111/all.14348,
author = {Johnston, SL},
doi = {10.1111/all.14348},
journal = {Allergy},
pages = {1543--1545},
title = {Asthma and COVID-19: is asthma a risk factor for severe outcomes?},
url = {http://dx.doi.org/10.1111/all.14348},
volume = {75},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - When I first read the manuscript that accompanies this editorial, upon its online publication on February 19th 2020(1), COVID-19 had already killed 2118 people in China, but only one person in Europe - an 80-year-old tourist from China, who died in France on the 15th February. I read the manuscript with grim fascination, as it was clear that SARS-CoV-2 had spread very rapidly in China which already had 74,576 cases and in South Korea which already had 58 cases, and that it was then invading Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countries too.
AU - Johnston,SL
DO - 10.1111/all.14348
EP - 1545
PY - 2020///
SN - 0105-4538
SP - 1543
TI - Asthma and COVID-19: is asthma a risk factor for severe outcomes?
T2 - Allergy
UR - http://dx.doi.org/10.1111/all.14348
UR - https://www.ncbi.nlm.nih.gov/pubmed/32358994
UR - https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14348
UR - http://hdl.handle.net/10044/1/78735
VL - 75
ER -